Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 6/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GPR52 | Q9Y2T5 | 2/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 2/20 | 0.35 |
| ▸ | HTR1A | P08908 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5133238 | 1.00 | AKR1C3 (0.42) | AKR1C3P2RX3FFAR4FFAR1ALDH1A1 | |
| SCHEMBL925940 | 0.89 | AKR1C3 (0.42) | AKR1C3P2RX3FFAR4FFAR1ALDH1A1 | |
| SCHEMBL5054277 | 0.89 | AKR1C3 (0.42) | AKR1C3P2RX3FFAR4FFAR1ALDH1A1 | |
| SCHEMBL4262893 | 0.82 | FFAR4 (0.53) | P2RX3FFAR4FFAR1 | |
| SCHEMBL10316590 | 0.78 | P2RX3 (0.40) | AKR1C3P2RX3FFAR4FFAR1LTA4H | |
| SCHEMBL927054 | 0.76 | CSNK2A1 (0.41) | P2RX3ALDH1A1RXRARXRBRXRG | |
| SCHEMBL926134 | 0.76 | AKR1C3 (0.54) | AKR1C3ALDH1A1CYP3A4ALOX5CYP2C9 | |
| SCHEMBL926135 | 0.76 | AKR1C3 (0.54) | AKR1C3ALDH1A1CYP3A4ALOX5CYP2C9 | |
| SCHEMBL3827746 | 0.76 | P2RX3 (0.41) | P2RX3RXRARXRBRXRGCYP1A2 | |
| SCHEMBL5133236 | 0.73 | AKR1C3 (0.37) | AKR1C3P2RX3ALDH1A1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1965915-B1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | RAPP POLYMERE GMBH (DE) | 2014-08-13 | — | — | EP | disclosed |
| US-20110009621-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | Raap Polymere GmbH (DE) | 2011-01-13 | — | — | US | disclosed |
| EP-1965915-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | Rapp Polymere GmbH (DE) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007065907-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | RAPP POLYMERE GMBH (DE) | 2007-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009621-A1 | SUPPORTED TRANSITION METAL COMPLEX AND USE THEREOF IN CATALYSIS | SCO2, SOD1, PPIF | AKR1C3 1244/4885P2RX3 4847/4885FFAR4 4669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.